Aktie A0M4G5 SHANDONG JINTAI GROUP CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Shandong Jintai Group Co., Ltd.

Aktien

A0M4G5

CNE0000018K3

600385

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shandong Jintai Group Co., Ltd. cancelled the transaction announced on March 4, 2021
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Shandong Jintai Group Co., Ltd. Auditor Raises 'Going Concern' Doubt
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shandong Jintai Group Co., Ltd. announced that it expects to receive CNY 155.956825 million in funding from Beijing Towercrest Investment Management Group Co., Ltd
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
Shandong Jintai Group Co., Ltd. Provides Earnings Guidance for the Year 2019
Shandong Jintai Group Co., Ltd. completed the acquisition of Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd.
Jinan Jintai Pharmaceutical Technology Development Co., Ltd. announced that it expects to receive $12 million in funding from Shandong Jintai Group Co., Ltd.
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
Shandong Jintai Group Co., Ltd. signed the share acquisition framework agreement to acquire Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd. for CNY 80 million.
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019
Shandong Jintai Group Co., Ltd. cancelled the acquisition of Fujian Meinkind Baby Products Co., Ltd. from 18 shareholders.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4G5 Aktie
  4. Nachrichten Shandong Jintai Group Co., Ltd.
  5. Andere Sprachen